Gentian Diagnostics AS (OSL:GENT) Operating Cash Flow per Share : kr1.08 (TTM As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Gentian Diagnostics AS Operating Cash Flow per Share?

Gentian Diagnostics AS's operating cash flow per share for the three months ended in Mar. 2025 was kr0.42. Gentian Diagnostics AS's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was kr1.08.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Gentian Diagnostics AS was -21.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Gentian Diagnostics AS's Operating Cash Flow per Share or its related term are showing as below:

During the past 12 years, Gentian Diagnostics AS's highest 3-Year average Operating Cash Flow per Share Growth Rate was 15.20% per year. The lowest was -96.70% per year. And the median was -22.40% per year.

OSL:GENT's 3-Year OCF Growth Rate is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 8.4
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Gentian Diagnostics AS Operating Cash Flow per Share Historical Data

The historical data trend for Gentian Diagnostics AS's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gentian Diagnostics AS Operating Cash Flow per Share Chart

Gentian Diagnostics AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.81

-1.76

-0.91

1.00

0.85

Gentian Diagnostics AS Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.17	-0.09	1.01	-0.26	0.42

Competitive Comparison of Gentian Diagnostics AS's Operating Cash Flow per Share

For the Medical Devices subindustry, Gentian Diagnostics AS's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gentian Diagnostics AS's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gentian Diagnostics AS's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Gentian Diagnostics AS's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Gentian Diagnostics AS Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Gentian Diagnostics AS's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	13.457	/	15.762
	=	0.85

Gentian Diagnostics AS's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2025 )	=	Cash Flow from Operations (Q: Mar. 2025 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2025 )
	=	6.591	/	15.762
	=	0.42

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1.08

Gentian Diagnostics AS Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Gentian Diagnostics AS's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Gentian Diagnostics AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gentian Diagnostics AS (OSL:GENT) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

GENTOo:Sweden 6FK:Germany

Address

Bjornasveien 5, Moss, NOR, 1596

Website

https://www.gentian.com

Gentian Diagnostics AS operates as a medical diagnostics company in Norway. It develops and produces in-vitro diagnostic reagents (IVD) for use in medical diagnostics and research. Its portfolio and pipeline of reagents span areas of inflammations, severe infections, kidney diseases, heart failures, and veterinary healthcare. The company's product portfolio includes the Gentian Cystatin C Immunoassay, the GCAL circulating calprotectin immunoassay (IVDR), the Gentian Retinol Binding Protein (RBP), and the Gentian Canine CRP among others. Geographically, it generates a majority of its revenue from Europe followed by Asia and the United States of America.